| Adela Virginia Taylor, M D | |
|
733 W Clairemont Ave, Eau Claire, WI 54701-6117 | |
| (715) 838-5222 | |
| Not Available |
| Full Name | Adela Virginia Taylor |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 31 Years |
| Location | 733 W Clairemont Ave, Eau Claire, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689664922 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 84784 (North Carolina) | Secondary |
| 207K00000X | Allergy & Immunology | 55853 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Health System Eau Claire Hospital | Eau claire, WI | Hospital |
| Mayo Clinic Health System-red Cedar Inc | Menomonie, WI | Hospital |
| Mayo Clinic Health System-northland | Barron, WI | Hospital |
| Mayo Clinic Health System Chippewa Valley | Bloomer, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic Health System-northwest Wisconsin Region Inc | 4385553627 | 623 |
News Archive
The COVID-19 pandemic is spreading over the world, causing panic and illness on a scale unprecedented in one hundred years. Even while the death toll nears 100,000, with over 1.5 million confirmed cases worldwide, public health experts and medical professionals are battling it using all the weapons available. Unfortunately, these are all too few.
MTBC, a leading provider of proprietary, web-based electronic health records, practice management and mHealth solutions, today announced the launch of PHR 2.0, an enhanced cutting-edge personal health record for patients.
Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration approved the daily pill Tarceva® (erlotinib) as a maintenance treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.
Using an innovative method to control the movement of Escherichia coli in a chemical environment, Emory University scientists have opened the door to powerful new opportunities in drug delivery, environmental cleanup and synthetic biology.
A recent article in the Journal of Thrombosis and Haemostasis determined that drinkers of wine benefit from its cardio-protective effects, more so than those who drink beer or other spirits, and may also live longer.
› Verified 6 days ago
| Entity Name | Mayo Clinic Health System-northwest Wisconsin Region Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235588831 PECOS PAC ID: 4385553627 Enrollment ID: O20161109002075 |
News Archive
The COVID-19 pandemic is spreading over the world, causing panic and illness on a scale unprecedented in one hundred years. Even while the death toll nears 100,000, with over 1.5 million confirmed cases worldwide, public health experts and medical professionals are battling it using all the weapons available. Unfortunately, these are all too few.
MTBC, a leading provider of proprietary, web-based electronic health records, practice management and mHealth solutions, today announced the launch of PHR 2.0, an enhanced cutting-edge personal health record for patients.
Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration approved the daily pill Tarceva® (erlotinib) as a maintenance treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.
Using an innovative method to control the movement of Escherichia coli in a chemical environment, Emory University scientists have opened the door to powerful new opportunities in drug delivery, environmental cleanup and synthetic biology.
A recent article in the Journal of Thrombosis and Haemostasis determined that drinkers of wine benefit from its cardio-protective effects, more so than those who drink beer or other spirits, and may also live longer.
› Verified 6 days ago
| Entity Name | Mayo Clinic Health System-northwest Wisconsin Region Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1740239557 PECOS PAC ID: 4385553627 Enrollment ID: O20171012000112 |
News Archive
The COVID-19 pandemic is spreading over the world, causing panic and illness on a scale unprecedented in one hundred years. Even while the death toll nears 100,000, with over 1.5 million confirmed cases worldwide, public health experts and medical professionals are battling it using all the weapons available. Unfortunately, these are all too few.
MTBC, a leading provider of proprietary, web-based electronic health records, practice management and mHealth solutions, today announced the launch of PHR 2.0, an enhanced cutting-edge personal health record for patients.
Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration approved the daily pill Tarceva® (erlotinib) as a maintenance treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.
Using an innovative method to control the movement of Escherichia coli in a chemical environment, Emory University scientists have opened the door to powerful new opportunities in drug delivery, environmental cleanup and synthetic biology.
A recent article in the Journal of Thrombosis and Haemostasis determined that drinkers of wine benefit from its cardio-protective effects, more so than those who drink beer or other spirits, and may also live longer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adela Virginia Taylor, M D Po Box 1510, Eau Claire, WI 54702-1510 Ph: (715) 838-5222 | Adela Virginia Taylor, M D 733 W Clairemont Ave, Eau Claire, WI 54701-6117 Ph: (715) 838-5222 |
News Archive
The COVID-19 pandemic is spreading over the world, causing panic and illness on a scale unprecedented in one hundred years. Even while the death toll nears 100,000, with over 1.5 million confirmed cases worldwide, public health experts and medical professionals are battling it using all the weapons available. Unfortunately, these are all too few.
MTBC, a leading provider of proprietary, web-based electronic health records, practice management and mHealth solutions, today announced the launch of PHR 2.0, an enhanced cutting-edge personal health record for patients.
Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration approved the daily pill Tarceva® (erlotinib) as a maintenance treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.
Using an innovative method to control the movement of Escherichia coli in a chemical environment, Emory University scientists have opened the door to powerful new opportunities in drug delivery, environmental cleanup and synthetic biology.
A recent article in the Journal of Thrombosis and Haemostasis determined that drinkers of wine benefit from its cardio-protective effects, more so than those who drink beer or other spirits, and may also live longer.
› Verified 6 days ago
Barry J Rhodes, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 733 W Clairemont Ave, Eau Claire, WI 54701 Phone: 715-838-5222 | |
Martin J Voss, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 733 W Clairemont Ave, Eau Claire, WI 54701 Phone: 715-838-5222 |